Back to news
Technology
Alphabet's Isomorphic Labs Raises $5 Billion for AI Drug Design
(4 days ago) · 1 source · Summarized by CryptoBipto
Isomorphic Labs, an Alphabet-owned company focused on using artificial intelligence for drug discovery, has raised $5 billion in funding. The round is one of the largest ever for an AI-focused biotech firm. The company applies deep learning techniques to design new pharmaceutical compounds.
WHY IT MATTERS
This story is about a major investment in artificial intelligence for healthcare, not about cryptocurrency directly.
Read the full analysis with a CryptoBipto membership
Members read why every story matters and the full analysis behind it.
SOURCES
- thedefiant.io
RELATED
AIBiotechVenture CapitalNon-Crypto
